BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Checkmahomed L, Padey B, Pizzorno A, Terrier O, Rosa-Calatrava M, Abed Y, Baz M, Boivin G. In Vitro Combinations of Baloxavir Acid and Other Inhibitors against Seasonal Influenza A Viruses. Viruses 2020;12:E1139. [PMID: 33049959 DOI: 10.3390/v12101139] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Tripp RA, Stambas J. Intervention Strategies for Seasonal and Emerging Respiratory Viruses with Drugs and Vaccines Targeting Viral Surface Glycoproteins. Viruses 2021;13:625. [PMID: 33917411 DOI: 10.3390/v13040625] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Taniguchi K, Ando Y, Kobayashi M, Toba S, Nobori H, Sanaki T, Noshi T, Kawai M, Yoshida R, Sato A, Shishido T, Naito A, Matsuno K, Okamatsu M, Sakoda Y, Kida H. Characterization of the In Vitro and In Vivo Efficacy of Baloxavir Marboxil against H5 Highly Pathogenic Avian Influenza Virus Infection. Viruses 2022;14:111. [PMID: 35062315 DOI: 10.3390/v14010111] [Reference Citation Analysis]
3 Gao Y, Cao J, Xing P, Altmeyer R, Zhang Y. Evaluation of Small Molecule Combinations against Respiratory Syncytial Virus In Vitro. Molecules 2021;26:2607. [PMID: 33946996 DOI: 10.3390/molecules26092607] [Reference Citation Analysis]
4 de St Maurice A, Martin-Blais R, Halasa N. Preparing for the 2020-2021 influenza season. Pediatr Transplant 2021;25:e14025. [PMID: 33904211 DOI: 10.1111/petr.14025] [Cited by in F6Publishing: 1] [Reference Citation Analysis]